Development of an in vitro multicellular tumor spheroid model using microencapsulation and its application in anticancer drug screening and testing

Biotechnology Progress

Volumn 21, Issue 4, 2005, Pages 1289-1296

  Zhang, Xulang ^a,b   Wang, Wei ^a   Yu, Weiting ^a   Xie, Yubing ^a   Zhang, Xiaohui ^a   Zhang, Ying ^a   Ma, Xiaojun ^a  

^a DALIAN INSTITUTE OF CHEMICAL PHYSICS   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CHEMOTHERAPY; MICROSCOPIC EXAMINATION; MONOLAYERS;

APOPTOTIC CELLS; CANCER CELLS; CHEMOTHERAPEUTIC DRUGS; MICROENCAPSULATION;

TUMORS;

DOXORUBICIN; FLUOROURACIL; MITOMYCIN;

ARTICLE; BREAST TUMOR; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; COMPARATIVE STUDY; CULTURE TECHNIQUE; DOSE RESPONSE; DRUG FORMULATION; DRUG SCREENING; HUMAN; METHODOLOGY; MULTICELLULAR SPHEROID; PATHOLOGY;

BREAST NEOPLASMS; CELL CULTURE TECHNIQUES; CELL PROLIFERATION; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG COMPOUNDING; DRUG SCREENING ASSAYS, ANTITUMOR; FLUOROURACIL; HUMANS; MITOMYCIN; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED;

MINK CELL FOCUS-FORMING VIRUS;

EID: 23244447397     PISSN: 87567938     EISSN: None     Source Type: Journal    
DOI: 10.1021/bp050003l     Document Type: Article

References (45)

1. Folkman, J. Tumour angiogenesis. Adv. Cancer Res. 1974, 19, 331.
2. Inch, W. R.; McCredie, J. A.; Sutherland, R. M. Growth of nodular carcinomas in rodents compared with multi-cell spheroids in tissue culture. Growth 1970, 34, 271-282.
3. Sutherland, R. M.; Inch, W. R.; McCredie, J. A.; Kruuv, J. A multicomponent radiation survival curve using an in vitro tumor model. Int. J. Radiat. Biol. Relat. Stud. Phys. Chem. Med. 1970, 18, 491-495.
4. Schwachofer, J. H. Multicellular tumor spheroids in radiotherapy research. Anticancer Res. 1990, 10, 963-970.
5. Desoize, B.; Gimonet, D.; Jordiller, J. C. Cell culture as spheroids: an approach to multicellular resistance. Anticancer Res. 1998, 18, 4147-4158.
6. Foster, T. H.; Hartley, D. F.; Nichols, M. G.; Hilf, R. Fluence rate effects in photodynamic therapy of multicell tumor spheroids. Cancer Res. 1993, 53, 1249-1254.
7. Steinbach, P.; Weingandt, H.; Baumgartner, R.; Kriegmair, M.; Hofstadter, F.; Knuchel, R. Cellular fluorescence of the endogenous photosensitizer protoporphyrin IX following exposure to 5-aminolevulinic acid. Photochem. Photobiol. 1995, 62, 887-895.
8. Iwasaki, K.; Kikuchi, H.; Miyatake, S.; Aoki, T.; Yamasaki, T.; Oda, Y. Intiltrative and cytolytic activities of lymphokine-activated killer cells against a human glioma spheroid model. Cancer Res. 1990, 50, 2429-2436.
9. Jaaskelainen, J.; Kalliomaki, P.; Paetau, A.; Timonen, T. Effect of LAK cells against three-dimensional tumor tissue. In vitro study using multicellular human glioma spheroids as targets. J. Immunol. 1989, 142, 1036-1045.
10. Bissell, M. J.; Barcellos-Hoff, M. H. The influence of extracellular matrix on gene expression: is structure the message? J. Cell Sci. Suppl. 1987, 8, 327-343.
11. Beningo, K. A.; Dembo, M.; Wang, Y. L. Responses of fibroblasts to anchorage of dorsal extracellular matrix receptors. Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (52), 18024-18029.
12. Engebraaten, O.; Bjerkvig, R.; Pedersen, P. H.; Laerum, O. D. Effects of EGF, bFGF, NGF and PDGF (bb) on cell proliferative, migratory and invasive capacities of human brain tumour biopsies in vitro. Int. J. Cancer 1993, 53 (2), 209-214.
13. Krauthauser, C. M.; Hall, L. A.; Wexler, R. S.; Slee, A. M.; Mitra, J.; Enders, G. H.; Kerr, J. S. Regulation of gene expression and cell growth in vivo by tetracycline using the hollow fiber assay. Anticancer Res. 2001, 21 (2A), 869-872.
14. Hassan, B. S.; Torre, L. M.; Nygren, P.; Karlsson, O. M.; Larsson, R.; Jonsson, E. A hollow fiber model for in vitro studies of cytotoxic compounds: activity of the cyanoguanidine CHS 828. Anti-Cancer Drugs 2001, 12, 33-42.
15. Griffith, L. G.; Naughton, G. Tissue engineering - current challenges and expanding opportunities. Science 2002, 295, 1009-1014.
16. Lim, F.; Sun, A. M. Microencapsulated islets as bioartificial endocrine pancreas. Science 1980, 210, 908-910.
17. Orive, G.; Hernandez, R. M.; Gascon, A. R.; Igartua, M.; Pedraz, J. L. Survival of different cell lines in alginate-agarose microcapsules. Eur. J. Pharm. Sci. 2003, 18, 23-30.
18. Liu, X. D.; He, Y.; Liu, Q.; Xiong, Y.; Fu, Y. L.; Ma, X. J.; Yu, X. J.; Yuan, Q. Microencapsulation and its application in biomedical field. Chin. Sci. Bull. 2000, 45, 2476-2485.
19. Mayer, B.; Klement, G.; Kaneko, M.; Man, S.; Jothy, S.; Rak, J.; Kerbel, R. S. Multicellular gastric cancer spheroids recapitulate growth pattern and differentiation phenotype of human gastric carcinomas. Gastroenterology 2001, 121 (4), 839-852.
20. Tannock, I. F. Combined modality treatment with radiotherapy and chemotherapy. Radiother. Oncol. 1989, 16 (2), 83-101.
21. Phillips, R. M.; Loadman, P. M.; Cronin, B. P. Evaluation of a novel in vitro assay for assessing drug penetration into avascular regions of tumours. Br. J. Cancer 1998, 77, 2112-2119.
22. Tunggal, J. K.; Cowan, D. S.; Shaikh, H.; Tannock, I. F. Penetration of anticancer drugs through solid tissue: a factor that limits the effectiveness of chemotherapy for solid tumors. Clin. Cancer Res. 1999, 5, 1583-1586.
23. Gorelik, E.; Ovejera, A.; Shoemaker, R.; Jarvis, A.; Alley, M.; Duff, R.; Mayo, J.; Herberman, R.; Boyd, M. Microencapsulated tumor assay: new short-term assay for in vivo evaluation of the effects of anticancer drugs on human tumor cell lines. Cancer Res. 1987, 47, 5739-5747.
24. Hwang, J. M.; Chen, C. F.; Hsu, W. L.; Chen, K. Y. A new in vivo assay of the reactions of microencapsulated human tumor cells to chemotherapeutic drugs. Zhonghua Yi Xue Za Zhi (Taipei) 1993, 51, 166-175.
25. Ma, X.; Vacek, I.; Sun, A. Generation of alginate-poly-L-lysine-alginate (APA) biomicrocapsules: the relationship between the membrane strength and the reaction conditions. Artificial Cells, Blood Subtitutes, Immobilization Biotechnol. 1994, 22 (1), 43-69.
26. Kusumoto, T.; Sakaguchi, Y.; Maehara, Y.; Nakashima, T.; Furusawa, M.; Sugimachi, K. Comparison of in vitro anti-cancer chemosensitivity between human squamous cell carcinoma and adenocarcinoma. Oncology 1992, 49, 343-346.
27. Uludag, H.; Sefton, M. V. Colorimetric assay for cellular activity in microcapsules. Biomaterials 1990, 11, 708-712.
28. Kiernan, J. A. Histological and Histochemical Methods; Butterworth-Heinemann: Oxford, 2000.
29. Hiroshi, W.; Masahiko, M.; Takehito, S. Differential effects of the Insulin-Like Growth Factor I receptor on radiosensitivity and spontaneous necrosis formation of human glioblastoma cells grown in multicellular spheroids. Exp. Cell Res. 1999, 250, 99-111.
30. Pancrazio, J. J.; Whelan, J. P.; Borkholder, D. A.; Ma, W.; Stenger, D. A. Development and application of cell-based biosensors. Ann. Biomed. Eng. 1999, 27, 697-711.
31. Bousse, L. Whole cell biosensors. Sens. Actuators, B 1996, 34, 270-275.
32. Santini, M. T.; Rainaldi, G. Three-dimensional spheroid model in tumor biology. Pathobiology 1999, 67, 148-157.
33. Li, C. H.; Luo, Y.; Xue, Y. L.; Liu C. G. Determination of the permeability of APA microcapsules by laser scanning confocal microscopy. Chin. J. Stereol. Image Anal. 1999, 4, 16-24.
34. Yang, X. L.; Wang, A. H. Structural studies of atom-specific anticancer drug acting on DNA. Pharmacol. Ther. 1999, 83, 181-215.
35. Knuchel, R.; Hofstadter, F.; Jenkins, W. E.; Masters, J. R. Sensitivities of monolayers and spheroids of the human bladder cancer cell line MGH-U1 to the drugs used for intravesical chemotherapy. Cancer Res. 1989, 49, 1397.
36. Oloumi, A.; MacPhail, S. H.; Johnston, P. J.; Banath, J. P.; Olive, P. L. Changes in subcellular distribution of topoisomerase IIa correlate with etoposide resistance in multicell spheroids and xenograft tumors. Cancer Res. 2000, 60, 5747.
37. Gerlowski, L. E.; Jain, R. K. Microvascular permeability of normal and neoplastic tissues. Microvasc. Res. 1986, 31, 288.
38. Jain, R. K. Barriers to drug delivery in solid tumors. Sci. Am. 1994, 271, 58.
39. Jain, R. K. Physiological barrier to delivery of monoclonal-antibodies and other macromolecules in tumours. Cancer Res. 1990, 50, 814.
40. Walker, J.; Martin, C.; Callaghan, R. Inhibition of P-glycoprotein function by XR9576 in a solid tumour model can restore anticancer drug efficacy. Eur. J. Cancer 2004, 40, 594-605.
41. Jackson, T. L.; Byrne, H. M. A mathematical model to study the e.ects of drug resistance and vasculature on the response of solid tumors to chemotherapy. Math. Biosci. 2000, 164, 17-38.
42. Halla, D.M.; Martin, C.; Ferguson, J. D.; Phillips, R. M.; Hambley, T. W.; Callaghan, R. Comparative efficacy of novel platinum (IV) compounds with established chemotherapeutic drugs in solid tumour models. Ferguson Biochem. Pharmacol. 2004, 67, 17-30.
43. Bauman, G. S.; Fisher, B. J.; McDonald, W.; Amberger, V. R.; Moore, E.; Del Maestro, R. F. Effects of radiation on a three-dimensional model of malignant glioma invasion. Int. J. Dev. Neurosci. 1999, 17, 643-651.
44. Mueller-Klieser, W. Tumor biology and experimental therapeutics. Crit. Rev. Oncol. Hematol. 2000, 36, 123-139.
45. Kunz-Schughart, L. A.; Doetsch, J.; Mueller-Klieser, W.; Groebe, K. Proliferative activity and tumorigenic conversion: impact on cellular metabolism in 3-D culture. Am. J. Physiol. Cell Physiol. 2000, 278, C765-780.